NMTR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

9 Meters Biopharma Insider Trading History Chart

9 Meters Biopharma Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

9 Meters Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/21/2023	Bethany Sensenig	CFO	Sell	9,100	$1.21	$11,011.00	41,077
7/6/2022	John Temperato	CEO	Buy	125,000	$0.23	$28,750.00	1,427,522
7/1/2022	Mark A. Sirgo	Director	Buy	175,000	$0.25	$43,750.00	1,454,045
3/3/2022	John Temperato	CEO	Buy	100,000	$0.56	$56,000.00
3/3/2022	Mark A. Sirgo	Director	Buy	86,450	$0.58	$50,141.00
12/2/2021	Mark A. Sirgo	Director	Buy	50,000	$0.89	$44,500.00
11/18/2021	John Temperato	CEO	Buy	50,000	$1.05	$52,500.00
11/18/2021	Mark A. Sirgo	Director	Buy	20,000	$1.06	$21,200.00
9/14/2021	Edward J. Sitar	CFO	Buy	15,000	$1.22	$18,300.00
9/7/2021	Mark A. Sirgo	Director	Buy	73,529	$1.36	$99,999.44
8/24/2021	Michael T. Constantino	Director	Buy	18,000	$1.14	$20,520.00
8/20/2021	Mark A. Sirgo	Director	Buy	25,000	$1.10	$27,500.00
8/18/2021	John Temperato	CEO	Buy	25,000	$1.05	$26,250.00	1,102,522
6/25/2021	Israel Gp Ltd. Orbimed	Major Shareholder	Sell	15,989,876	$1.21	$19,347,749.96
6/23/2021	Israel Gp Ltd. Orbimed	Major Shareholder	Sell	841,650	$1.36	$1,144,644.00

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

SEC Filings (Institutional Ownership Changes) for 9 Meters Biopharma (NASDAQ:NMTR)

22.34% of 9 Meters Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

9 Meters Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/9/2023	ODonnell Financial Services LLC	43,410	$55K	0.5%	-95.1%	0.335%
2/7/2023	Commonwealth Equity Services LLC	38,141	$48K	0.0%	-90.3%	0.295%
1/19/2023	Adviser Investments LLC	21,429	$49K	0.0%	-92.3%	0.165%
11/16/2022	Requisite Capital Management LLC	300,000	$65K	0.0%	N/A	2.317%
11/15/2022	Laurion Capital Management LP	4,558,200	$0.98M	0.0%	+0.1%	35.198%
11/14/2022	Ergoteles LLC	911,451	$0.20M	0.0%	-8.5%	7.036%
11/7/2022	Virtu Financial LLC	228,595	$49K	0.0%	+25.6%	1.765%
10/31/2022	Valeo Financial Advisors LLC	209,688	$45K	0.0%	+5.8%	1.619%
8/15/2022	Laurion Capital Management LP	4,553,084	$1.19M	0.0%	N/A	1.757%
8/8/2022	Curi Wealth Management LLC	2,072,771	$0.54M	0.1%	+17,757.9%	0.800%
8/8/2022	Y Intercept Hong Kong Ltd	184,315	$48K	0.0%	N/A	0.071%
7/19/2022	Commonwealth Equity Services LLC	290,402	$75K	0.0%	+38.0%	0.112%
7/14/2022	Adviser Investments LLC	286,248	$75K	0.0%	+24.0%	0.110%
5/11/2022	GSA Capital Partners LLP	419,858	$0.25M	0.0%	-15.3%	0.163%
5/4/2022	Adviser Investments LLC	230,888	$0.14M	0.0%	+261.0%	0.089%
5/4/2022	Commonwealth Equity Services LLC	210,402	$0.13M	0.0%	+22.3%	0.081%
2/16/2022	Ghost Tree Capital LLC	3,250,000	$3.18M	1.1%	+18.2%	1.271%
2/14/2022	Blair William & Co. IL	81,912	$80K	0.0%	+192.5%	0.032%
2/14/2022	GSA Capital Partners LLP	495,783	$0.49M	0.1%	+3,414.2%	0.194%
2/9/2022	Principal Financial Group Inc.	68,709	$67K	0.0%	-23.0%	0.027%
2/8/2022	ProShare Advisors LLC	49,462	$48K	0.0%	+72.8%	0.019%
2/8/2022	Northern Trust Corp	2,136,520	$2.09M	0.0%	+2.1%	0.836%
2/7/2022	SG Americas Securities LLC	57,608	$56K	0.0%	-46.6%	0.023%
1/31/2022	Commonwealth Equity Services LLC	172,102	$0.17M	0.0%	+12.4%	0.067%
1/31/2022	Adviser Investments LLC	63,955	$63K	0.0%	N/A	0.025%
1/25/2022	J.W. Cole Advisors Inc.	45,000	$44K	0.0%	+50.0%	0.018%
11/16/2021	Schonfeld Strategic Advisors LLC	39,300	$51K	0.0%	N/A	0.015%
11/16/2021	Captrust Financial Advisors	29,844	$39K	0.0%	-74.8%	0.012%
11/16/2021	Two Sigma Securities LLC	24,834	$32K	0.0%	N/A	0.010%
11/16/2021	Metropolitan Life Insurance Co NY	64,133	$83K	0.0%	N/A	0.025%
11/12/2021	Geode Capital Management LLC	3,624,058	$4.71M	0.0%	+7.4%	1.423%
11/10/2021	Mercer Global Advisors Inc. ADV	60,000	$78K	0.0%	N/A	0.024%
11/10/2021	Panagora Asset Management Inc.	315,867	$0.41M	0.0%	N/A	0.124%
11/10/2021	Prentice Wealth Management LLC	29,000	$38K	0.0%	+59.3%	0.011%
11/10/2021	Citigroup Inc.	27,474	$36K	0.0%	+78.3%	0.011%
11/9/2021	BlackRock Inc.	13,566,265	$17.64M	0.0%	+0.6%	5.325%
11/9/2021	Boston Private Wealth LLC	26,000	$34K	0.0%	N/A	0.010%
11/8/2021	State Board of Administration of Florida Retirement System	52,330	$68K	0.0%	N/A	0.021%
11/5/2021	Advisor Group Holdings Inc.	62,547	$81K	0.0%	+84.0%	0.025%
11/4/2021	Almanack Investment Partners LLC.	40,850	$53K	0.0%	-21.7%	0.016%
11/4/2021	Deutsche Bank AG	1,078,613	$1.40M	0.0%	-65.9%	0.423%
11/2/2021	New York State Common Retirement Fund	103,586	$0.14M	0.0%	-43.1%	0.041%
11/1/2021	SG Americas Securities LLC	107,970	$0.14M	0.0%	+292.0%	0.042%
10/29/2021	Commonwealth Equity Services LLC	153,052	$0.20M	0.0%	+101.4%	0.060%
10/29/2021	ODonnell Financial Services LLC	840,727	$1.09M	0.5%	N/A	0.330%
10/15/2021	Paradigm Strategies in Wealth Management LLC	30,800	$40K	0.0%	+185.2%	0.012%
9/17/2021	Virtu Financial LLC	168,722	$0.19M	0.0%	+42.4%	0.066%
8/17/2021	Millennium Management LLC	2,806,866	$3.09M	0.0%	+50.0%	1.117%
8/16/2021	Squarepoint Ops LLC	23,262	$26K	0.0%	-84.0%	0.009%
8/16/2021	Amalgamated Bank	40,133	$44K	0.0%	N/A	0.016%
8/16/2021	Cubist Systematic Strategies LLC	208,581	$0.23M	0.0%	+388.5%	0.083%
8/16/2021	California State Teachers Retirement System	293,497	$0.32M	0.0%	N/A	0.117%
8/16/2021	Charles Schwab Investment Management Inc.	518,627	$0.57M	0.0%	+662.2%	0.206%
8/16/2021	State Street Corp	2,976,803	$3.27M	0.0%	N/A	1.184%
8/16/2021	Nuveen Asset Management LLC	1,213,239	$1.33M	0.0%	N/A	0.483%
8/13/2021	Renaissance Technologies LLC	1,305,027	$1.44M	0.0%	N/A	0.519%
8/13/2021	Northern Trust Corp	733,042	$0.81M	0.0%	+128.5%	0.292%
8/13/2021	Qube Research & Technologies Ltd	274,665	$0.30M	0.0%	+27.0%	0.109%
8/13/2021	Geode Capital Management LLC	3,373,509	$3.71M	0.0%	+157.7%	1.342%
8/13/2021	Vanguard Group Inc.	10,925,887	$12.02M	0.0%	+21.5%	4.347%
8/13/2021	ProShare Advisors LLC	55,135	$61K	0.0%	N/A	0.022%
8/12/2021	SG Americas Securities LLC	27,541	$30K	0.0%	N/A	0.011%
8/12/2021	Legal & General Group Plc	22,477	$25K	0.0%	N/A	0.009%
8/12/2021	JPMorgan Chase & Co.	139,530	$0.15M	0.0%	N/A	0.056%
8/12/2021	The Manufacturers Life Insurance Company	141,330	$0.16M	0.0%	N/A	0.056%
8/11/2021	Bank of New York Mellon Corp	481,547	$0.53M	0.0%	+727.7%	0.192%
8/11/2021	BlackRock Inc.	13,484,537	$14.83M	0.0%	+258.5%	5.364%
8/11/2021	Deutsche Bank AG	3,165,872	$3.48M	0.0%	+2,367.3%	1.259%
8/10/2021	Principal Financial Group Inc.	83,859	$92K	0.0%	N/A	0.033%
8/5/2021	Rhumbline Advisers	144,474	$0.16M	0.0%	N/A	0.057%
8/2/2021	New York State Common Retirement Fund	182,100	$0.20M	0.0%	N/A	0.072%
8/2/2021	Advisor Group Holdings Inc.	34,000	$38K	0.0%	+126.7%	0.014%
7/30/2021	Alliancebernstein L.P.	37,400	$41K	0.0%	N/A	0.015%
7/22/2021	Meridian Wealth Management LLC	100,000	$0.11M	0.0%	+900.0%	0.040%
5/19/2021	Virtu Financial LLC	118,491	$0.14M	0.0%	N/A	0.047%
5/19/2021	Squarepoint Ops LLC	145,724	$0.17M	0.0%	N/A	0.058%
5/18/2021	Millennium Management LLC	1,871,798	$2.19M	0.0%	+987.5%	0.745%
5/18/2021	Tudor Investment Corp Et Al	72,100	$84K	0.0%	N/A	0.029%
5/18/2021	Cubist Systematic Strategies LLC	42,700	$50K	0.0%	N/A	0.017%
5/17/2021	Schonfeld Strategic Advisors LLC	57,258	$67K	0.0%	N/A	0.023%
5/17/2021	Walleye Capital LLC	150,000	$0.18M	0.0%	N/A	0.060%
5/17/2021	Nomura Holdings Inc.	133,500	$0.16M	0.0%	N/A	0.053%
5/17/2021	HRT Financial LP	573,406	$0.67M	0.0%	N/A	0.228%
5/17/2021	Goldman Sachs Group Inc.	88,197	$0.10M	0.0%	N/A	0.035%
5/14/2021	HN Saltoro Capital LP	90,000	$0.11M	0.0%	-87.1%	0.042%
5/13/2021	Bank of New York Mellon Corp	58,176	$68K	0.0%	N/A	0.027%
5/13/2021	Citigroup Inc.	800,000	$0.94M	0.0%	N/A	0.370%
5/12/2021	Northern Trust Corp	320,745	$0.38M	0.0%	+50.8%	0.148%
5/12/2021	Geode Capital Management LLC	1,309,144	$1.53M	0.0%	+62.7%	0.606%
5/12/2021	MYDA Advisors LLC	40,000	$47K	0.0%	-88.9%	0.019%
5/12/2021	UBS Group AG	35,520	$42K	0.0%	-52.7%	0.016%
5/11/2021	Almanack Investment Partners LLC.	52,450	$61K	0.0%	N/A	0.024%
5/7/2021	BlackRock Inc.	3,761,047	$4.40M	0.0%	+23.9%	1.741%
5/4/2021	Commonwealth Equity Services LLC	72,602	$84K	0.0%	+380.7%	0.034%
5/4/2021	Ieq Capital LLC	84,000	$98K	0.0%	N/A	0.039%
5/3/2021	Chartwell Investment Partners LLC	471,604	$0.55M	0.0%	N/A	0.218%
4/28/2021	Perkins Capital Management Inc.	350,000	$0.41M	0.2%	+16.7%	0.162%
4/26/2021	Ascent Wealth Partners LLC	85,224	$100K	0.0%	N/A	0.039%
4/12/2021	Valeo Financial Advisors LLC	198,148	$0.23M	0.0%	+358.2%	0.092%
2/17/2021	Worth Venture Partners LLC	789,341	$0.68M	0.5%	N/A	0.525%

Data available starting January 2016

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. 9 Meters Biopharma, Inc. is headquartered in Raleigh, North Carolina. On July 17, 2023, 9 Meters Biopharma, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.

Today's Range

Now: N/A

50 Day Range

MA: $0.01

$0.00

$0.02

52 Week Range

Now: N/A

Volume

76 shs

Average Volume

315,915 shs

Market Capitalization

$1.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Who are the company insiders with the largest holdings of 9 Meters Biopharma?: 9 Meters Biopharma's top insider shareholders include:
Mark A Sirgo (Director)
John Temperato (CEO)
Bethany Sensenig (CFO)
Learn More about top insider investors at 9 Meters Biopharma.